Abstract
Respiratory infections are the most common causes of illness among children. Differences in anatomy and physiology makes children more vulnerable to severe respiratory dysfunction than adults. Nebulized therapy has a very important role in pediatric practice. The purpose of the study was to present the guidelines on nebulization with 3% hypertonic saline.References
Taylor C, Lillis C, LeMone P. Fundaments of nursing. 4th ed. Philadelphia: Lippincott; 2001: 1233–1246.
Zang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2013; 7: 1–5.
Sharma BS, Gupta MK, Rafik SP. Hypertonic (3%) saline vs 0.93% saline nebulization for acute viral bronchiolitis: a randomized controlled trial. Indian Pediatr 2013; 50(8): 743–747.
Mandelberg A, Tal G, Witzling M, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003; 123(2): 481–487.
Sarrell EM, Tal G, Witzling M, et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest 2002; 122(6): 2015–2020.
Mandelberg A, Tal G, Witzling M, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003; 123(2): 481–487.